An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer

An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 30; pp. ii65 - ii66
Main Authors: Spicer, J., Provencio, M., Garrido Lopez, P., Bosch-Barrera, J., de Castro Carpeño, F.J., Felip, E., Trigo, J., Viteri, S., Coart, E., Schmidt, E., Christiansen, A.V., Zocca, M.-B., Andersen, M.H., Ehrnrooth, E., Paz-Ares, L.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-04-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdz063.078